BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 224 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,114,000 | +18.1% | 7,644 | -3.9% | 0.02% | +46.2% |
| Q1 2022 | $943,000 | -14.1% | 7,953 | -0.3% | 0.01% | -13.3% |
| Q4 2021 | $1,098,000 | +254.2% | 7,973 | +257.2% | 0.02% | +275.0% |
| Q3 2021 | $310,000 | +39.0% | 2,232 | -2.9% | 0.00% | +33.3% |
| Q2 2021 | $223,000 | +2.8% | 2,298 | -9.2% | 0.00% | -25.0% |
| Q4 2020 | $217,000 | +138.5% | 2,531 | -5.6% | 0.00% | +100.0% |
| Q1 2020 | $91,000 | -40.9% | 2,681 | -5.1% | 0.00% | -33.3% |
| Q4 2019 | $154,000 | +29.4% | 2,825 | -0.7% | 0.00% | 0.0% |
| Q3 2019 | $119,000 | – | 2,844 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 450,422 | $6,251,857 | 14.11% |
| Liontrust Investment Partners LLP | 134,659 | $7,478,961 | 0.13% |
| Birchview Capital, LP | 7,365 | $102 | 0.07% |
| FNY Investment Advisers, LLC | 250 | $3 | 0.00% |
| FNY Investment Advisers, LLC | 18 | $0 | 0.00% |
| FNY Investment Advisers, LLC | 56 | $0 | 0.00% |
| McElhenny Sheffield Capital Management, LLC | 31 | $430 | 0.00% |
| Blue Trust, Inc. | 65 | $10 | 0.00% |
| IFP Advisors, Inc | 1 | $1 | 0.00% |